FDA Device Intelligence
Home › Instant Technologies, Inc. › Alere iCup Dx 14

Alere iCup Dx 14

Instant Technologies, Inc. · Model I-DXA-2147-011 · UDI-DI 00817405020027

LFHLCMDJGDJCLDJDIODKZDISJXMDJRLAFJXN Prescription
1
510(k) clearances
1
Adverse events
3
Recalls
7
Facilities

Description

Urine Drug Screen Cup for detection of 14 drugs, Amphetamine, Barbiturate, Benzodiazepine, Buprenorphine, Cocaine, Ecstasy, Marijuana, Methadone, Methamphetamine, Morphine, Oxycodone, Phencyclidine, Propoxyphene and Tricyclic Antidepressants with adulteration tests, Bleach, Creatinine, Nitrite, pH and Specific Gravity, CLIA Waived

Recalls

DateFirmReason
2017-12-15Ameditech IncThe kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box.
2017-06-26Ameditech IncThe kit box label incorrectly identifies PCP (instead of TCA) as one of the 10 drug analytes included in the kit. The pouch label, product insert, and the device itself are labeled
2003-11-17Abbott Health Products, Inc.Drug product cross reacts with the Tricyclic Antidepressants (TCA) assay.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.